Endo Transvaginal Announcement

The New York Times reported yesterday that Endo International agreed to pay $830 million to resolve legal claims from women who say they were injured by transvaginal mesh devices marketed by the company..

The company still refuses to admit liability or fault for the defective devices, but announced that the agreement would cover most of the mesh litigation brought against its American Medical Systems subsidiary.

The claims Endo is agreeing to settle are among thousands that have been filed against medical device makers. Along with Endo and American Medical Systems, suits have been brought against C.R. Bard, Boston Scientific, and Johnson & Johnson’s Ethicon unit.

These lawsuits have been filed across the country by thousands of women who suffered horrific complications following implantation of pelvic mesh during uro-gynecological surgeries to treat pelvic organ prolapse and stress urinary incontinence.

Last year Endo agreed to pay $54.5 million to settle an undisclosed number of mesh cases, and indicated in their most recent SEC filing – that Endo and American Medical together face about 22,000 lawsuits over the devices.

Endo and the other manufacturers of transvaginal mesh continue to deny responsibility for the horrible problems experienced by women who have received their faulty devices. Yet Endo is willing to pay almost $900 million to victims, and still try and maintain the façade that they are neither liable or at fault?

How many more women will have to suffer? How much money will it take for Endo to admit they sold a dangerous product that was defectively manufactured and inadequately tested?